CTOs on the Move

Salter Labs

www.salterlabs.com

 
Since 1976, Salter Labs has positioned itself to approach both the hospital and home care markets with products reflecting both innovation and exceptional quality.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Medical Management Strategies

Medical Management Strategies is a San Luis Obispo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Disability Management Network

Disability Management Network is a Forest Park, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Healthcare Commons Inc

Healthcare Commons Inc is a Penns Grove, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Blueprint Medicines

Blueprint Medicines is developing a new generation of highly selective and potent kinase therapies to dramatically improve the lives of patients with genomically defined diseases. Our approach is rooted in a deep understanding of the genetic blueprint of cancer and other diseases driven by the abnormal activation of kinases. Our ability to identify novel drivers of disease, coupled with our proprietary library of novel and diverse chemical compounds, uniquely enables us to craft kinase therapies against new and difficult-to-drug targets. We are boldly advancing a deep pipeline of highly targeted therapies against previously unaddressed drivers of disease. By focusing on genomically defined subsets of patients, we believe we can identify the people most likely to respond to our therapies, resulting in a more efficient clinical development path with a greater likelihood of success and better outcomes for patients. We see a substantial opportunity in kinase drug discovery and development to deliver breakthrough medicines that allow patients to live longer with better quality of life and prevent recurrences of disease. Kinases are involved in many hallmarks of tumor biology and are proven cancer drug targets. Currently approved drugs focus on less than 5 percent of known kinases, and the function of most kinases is unknown. Led by a team of industry innovators with a track record of bringing life-changing drugs to market, we believe Blueprint Medicines has the experience and expertise to deliver on the tremendous untapped potential of kinase therapies to improve patients’ lives. We don’t think in small steps. We think in giant leaps. We are driven by the pursuit of new ideas, new innovations, and new ways of thinking.

United Methodist Communities

You will find comfort, security, and gracious services that exceed your expectations in our communities. A caring staff will provide thoughtful attention to your needs. Old friends will want to visit. New neighbors will welcome you. The amenities of shops, restaurants, entertainment, events and churches are readily accessible in town. Year after year, residents and staff award our communities the highest satisfaction ratings in an independent survey.